Mathematical models for predicting how cancer tumors in mice grow over time can give distorted results if unmeasurable data ...

Ashley Robinson, 35, told doctors about his family history of colon cancer, but says they insisted he was "too young” for the ...

Telomir-1 shows potential in oncology and age-related diseases, with new findings on its role in tumor suppression and ...

Current guidelines lack consensus and rely on lower-quality evidence, according to the author of new research.

New magnetic nanoparticles in the shape of a cube sandwiched between two pyramids represent a breakthrough for treating ovarian tumors and possibly other types of cancer.

The American Medical Association and more than two dozen other health organizations joined in an amicus brief encouraging the ...

Phyllodes tumors, varying from benign to malignant, need precise diagnosis and surgery, with a focus on multidisciplinary ...

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment ...

Among patients with renal cell carcinoma, those with larger tumors may yield the most benefit from SBRT compared with other ...

Parkway Cancer Center provides personalized care and cutting-edge medical advancements that enhance colorectal cancer ...

This groundbreaking finding suggests that Telomir-1 may selectively benefit healthy cells while suppressing malignant growth, challenging the assumption that telomere-elongating drugs inherently ...

“That's when they found a tumor the size of an orange in my colon,” Robinson told the outlet. “I was dreading getting the results back. I was told I had stage four colon cancer, which had ...